Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies

被引：0
|
作者：
Gupta, Gopal N. [1 ]
Hart, Spencer [1 ]
机构：
[1] Loyola Univ Med Ctr, Dept Urol, Urol Oncol, Maywood, IL 60153 USA
来源：
UROLOGY | 2020年 / 137卷
关键词：
D O I：
10.1016/j.urology.2019.10.043
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131 / 132
页数：2
相关论文
共 50 条
  • [21] Eligibility for focal treatment of ISUP grade 2 single lesion on MRI-targeted biopsies
    Bajeot, A. S.
    Albisinni, S.
    Roumeguere, T.
    Fiard, G.
    Lesourd, M.
    Manceau, C.
    Salin, A.
    Loison, G.
    Doumerc, N.
    Thoulouzan, M.
    Tollon, C.
    Almeras, C.
    Gautier, J-R.
    Game, X.
    Soulie, M.
    Beauval, J-B.
    Diamand, R.
    Ploussard, G.
    Roumiguie, M.
    EUROPEAN UROLOGY, 2021, 79 : S1488 - S1489
  • [22] Can MRI replace serial biopsies in men on active surveillance for prostate cancer?
    Moore, Caroline M.
    Petrides, Neophytos
    Emberton, Mark
    CURRENT OPINION IN UROLOGY, 2014, 24 (03) : 280 - 287
  • [23] MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial
    Eklund, M.
    Jaderling, F.
    Discacciati, A.
    Bergman, M.
    Annerstedt, M.
    Aly, M.
    Glaessgen, A.
    Carlsson, S.
    Gronberg, H.
    Nordstrom, T.
    EUROPEAN UROLOGY, 2021, 79 : S1430 - S1430
  • [24] Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI
    Gayet, Maudy C. W.
    Aa, Anouk A. M. A. van der
    Beerlage, Harrie P.
    Schrier, Bart Ph
    Gielens, Maaike
    Heesakkers, Roel
    Jager, Gerrit J.
    Mulders, Peter F. A.
    Wijkstra, Hessel
    PROSTATE CANCER, 2020, 2020
  • [25] Reduced disqualification rates when MRI-targeted transperineal fusion biopsies are used instead of standard 12-core systematic biopsies for selection of prostate cancer patients for active surveillance
    Radtke, J. P.
    Kuru, T.
    Bonekamp, D.
    Freitag, M.
    Mueller-Wolf, M.
    Alt, C.
    Hatiboglu, G.
    Boxler, S.
    Pahernik, S.
    Roth, W.
    Roethke, M.
    Schlemmer, H. -P.
    Hohenfellner, M.
    Hadaschik, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 20 - 20
  • [26] Do Targeted Ultrasound/MRI Fusion Biopsies Significantly Change Maximum Prostate Gleason Score Compared With Systematic Biopsies?
    Kamrava, M.
    Chang, E.
    Dorey, F.
    Kupelian, P.
    Marks, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S23 - S24
  • [27] THERE IS NO WAY TO AVOID CONCOMITANT SYSTEMATIC PROSTATE BIOPSIES IN ADDITION TO MP-MRI TARGETED SAMPLING IN MEN WITH POSITIVE IMAGING
    Dell'Oglio, Paolo
    Stabile, Armando
    Soligo, Matteo
    Zaffuto, Emanuele
    De Cobelli, Francesco
    Brembilla, Giorgio
    Cannoletta, Donato
    Gandaglia, Giorgio
    Fossati, Nicola
    Esposito, Antonio
    Del Maschio, Alessandro
    Boeri, Luca
    Suardi, Nazareno
    Karnes, R. Jeffrey
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2019, 201 (04): : E519 - E519
  • [28] GLEASON SCORING OF PROSTATE BIOPSIES IN ACTIVE SURVEILLANCE PATIENTS OBTAINED BY STANDARD TRUS AND MRI: AN UPDATE
    Bienvenu, James
    Haddock, Peter
    Cusano, Joseph
    Wagner, Joseph
    JOURNAL OF UROLOGY, 2016, 195 (04): : E167 - E167
  • [29] CAN SURVEILLANCE BIOPSIES BE OMITTED AT FIRST MRI-INFORMED SURVEILLANCE BIOPSY IN LOW-RISK PROSTATE CANCER PATIENTS WITH NEGATIVE MRI ON ACTIVE SURVEILLANCE
    Chappidi, Meera R.
    Newcomb, Lisa F.
    Liu, Menghan
    Schenk, Jeannette M.
    Zheng, Yingye
    Zhu, Kehao
    de la Calle, Claire M.
    Lin, Daniel W.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E264 - E264
  • [30] Is it safe to omit systematic biopsies in addition to targeted MRI-ultrasound fusion biopsies in biopsy naive men suspected for prostate cancer?
    Alkema, N. G.
    Hoogeveen, F. J. S.
    Cauberg, E.
    Witte, L. P. W.
    Boomsma, M. F.
    Van'T Veer-Ten Kate, M.
    De Boer, E.
    Hoogland, A. M.
    Blanker, M. H.
    Steffens, M. G.
    EUROPEAN UROLOGY, 2021, 79 : S1323 - S1323
12345